Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
Open Access
- 7 February 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 393 (10174), 877-888
- https://doi.org/10.1016/s0140-6736(19)30038-8
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (NHMRC) of Australia (1020462, 1101113)
- UK Stroke Association (2012/01 and 2015/01)
- National Council for Scientific and Technological Development of Brazil (467322/2014–7, 402388/2013–5)
This publication has 23 references indexed in Scilit:
- Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral HemorrhageThe New England Journal of Medicine, 2013
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- Cerebral Autoregulation in StrokeStroke, 2010
- Postthrombolysis Blood Pressure Elevation Is Associated With Hemorrhagic TransformationStroke, 2010
- Relationship Between Therapeutic Changes in Blood Pressure and Outcomes in Acute StrokeHypertension, 2009
- Blood pressure as a prognostic factor after acute strokeThe Lancet Neurology, 2009
- Reliability of the Modified Rankin ScaleStroke, 2009
- Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous ThrombolysisStroke, 2009
- Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled TrialsStroke, 2008
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001